FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$16.81
-0.24 (-1.41%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.76
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.10
12.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $16.81, which is considered oversold relative to its 30-day fair value range of $16.58 to $17.71. The stock's valuation (Forward PE: 21.5) is in line with its historical norms (20.2). At these levels, the market is pricing in 2.0% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $15.37, while resistance sits at $17.81.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $15.37, while resistance sits at $17.81.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$16.58 -
$17.71
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($16.44)
- BULLISH: Expecting earnings turnaround to 2.0% growth with 3.9% revenue growth
Fair Price Analysis
30-Day Fair Range
$16.58 -
$17.71
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$15.37
Resistance Level
$17.81
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
21.50
Wall Street Target
$16.44
(-2.2%)
Revenue Growth (YoY)
3.9%
Earnings Growth (YoY)
-57.4%
Profit Margin
-36.8%
Valuation Premium vs History
+2.0% premium
PE vs Historical
21.5 vs 20.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.0%
(market-implied from PE analysis)
1-Year Target
$17.15
(+2%)
2-Year Target
$17.49
(+4%)
3-Year Target
$17.84
(+6%)
3-Yr Target (if PE normalizes)
(PE: 22→20)
PE COMPRESSION
$16.76
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 53.6%)
$58.85
(+250%)
Base:
(SPY PE: 21.5, Growth: 53.6%)
$56.73
(+238%)
Bear:
(PE: 18.3, Growth: 53.6%)
$48.22
(+187%)
Last updated: February 01, 2026 4:48 AM ET
Data refreshes hourly during market hours. Next update: 5:48 AM
Data refreshes hourly during market hours. Next update: 5:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
3
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
James S Hanson
SELL
1677 shares
2025-09-09
Jill G Mcconnell
SELL
3156 shares
2025-09-09
Robert Parks
SELL
592 shares
2025-09-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced FTRE Option Strategies
Professional options setups generated by AI based on today's FTRE price and gamma walls.
